Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 7356 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Akerman group study describes first new all-optical tool for quantifying inhibitory receptor driving forces

A new paper from the Akerman group, published in the journal Nature Communications this week, explains the development of a new ‘ORCHID’ (Optical Reporting of CHloride Ion Driving) biosensor to measure the driving force acting on inhibitory receptors in the brain.

Kavli Oxford's Nick Gatford Wins Image of Distinction Award in Nikon Small World Competition

Dr Nick Gatford, from Professor George Tofaris' Lab at Kavli Oxford, has won an Image of Distinction Award in the 50th anniversary of the Nikon Small World competition.

New Minichiello research explores the role of cell dysfunction in ataxic symptoms

A new study from the Minichiello group, published recently in the journal Biology, has shown that dysfunction in BDNF-TrkB signalling, restricted to a specific subset of cerebellar granule cells, is sufficient to generate ataxic symptoms

35 Years of the MRC WIMM- Medical Research Council Weatherall Institute of Molecular Medicine

In 1989, Sir David Weatherall founded the Institute of Molecular Medicine to bridge the gap between basic science and clinical medicine. To mark 35 years since the MRC WIMM opened its labs, we're looking back on some of our highlights and achievements.

Cellular roadmap reveals new paths to treating inflammatory bowel disease

In a world first, researchers at the Kennedy Institute, Oxford have mapped the cellular dynamics following treatment with the most commonly used advanced therapy in autoimmune diseases. They have discovered why some patients benefit from this therapy while others do not, potentially paving the way for new therapies.

New Type 1 Diabetes Grand Challenge funding to develop drugs from bugs

Today the Type 1 Diabetes Grand Challenge, a trailblazing partnership between the Steve Morgan Foundation, Diabetes UK, and Breakthrough T1D (formerly JDRF) has announced funding for a cutting-edge research project led by researchers in the Radcliffe Department of Medicine, which could bring us closer to a cure for type 1 diabetes.

Professor Sir Aziz Sheikh, Head of Department, elected to prestigious U.S. National Academy of Medicine

We are delighted to share that Professor Sir Aziz Sheikh OBE, NDPCHS Head of Department and Nuffield Professor of Primary Care Health Sciences, has been elected to the esteemed National Academy of Medicine (NAM) in the United States.

Four Oxford researchers win prestigious Philip Leverhulme Prizes

Awarded by the Leverhulme Trust, Philip Leverhulme Prizes recognise the achievement of outstanding research scholars whose future career is exceptionally promising, and whose work has made original and significant contributions to knowledge as well as shown sustained international impact.

Study Publishes New Insights on Goblet Cell Differentiation in Colorectal Cancer

The Oncology Department at the University of Oxford is excited to announce the forthcoming publication in the Proceedings of the National Academy of Sciences (PNAS) of the research paper “Goblet Cell Differentiation Subgroups in Colorectal Cancer.” This groundbreaking study sheds light on the role of goblet cell differentiation in colorectal cancer (CRC) and its impact on cancer progression and prognosis.

Professor Sir John Bell – reflecting on ten years as OAHP Chair

Having recently stepped down from his role as founding Chair of the Oxford Academic Health Partners, Professor Sir John Bell reflects on his pivotal moments at Oxford, the challenges of establishing the city’s academic health partnership, and why a dedicated national health innovation fund could be key to addressing some of the NHS’s toughest challenges.

Typhoid vaccine trial confirms sustained protection for older children

A single dose of typhoid conjugate vaccine (TCV) offers safe, effective protection against typhoid two years after vaccination in all children, and sustained protection for older children at three to five years post immunisation, according to a report by researchers at the Oxford Vaccine Group and the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). But it also shows a decline in protection at the later timepoints among children vaccinated at younger ages.

Bodleian Libraries Update - Oct 2024 - Wellbeing events | Rights retention | New resource

New research network unites Oxford University’s global fight against antimicrobial resistance

A new University-wide network on antimicrobial resistance aims to generate novel research and collaborations to tackle one of the most urgent global health threats.

Oxford researchers secure funding for world's first ovarian cancer prevention vaccine

Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

US adults in worse health than British counterparts at midlife

US adults have significantly worse health in midlife compared to their British peers, especially in markers of cardiovascular health, according to a new study involving researchers from Oxford’s Leverhulme Centre for Demographic Science, published in the International Journal of Epidemiology.

Professor Prabhat Jha appointed as Nuffield Professor of Population Health and Head of Department

Professor Prabhat Jha has been appointed as Nuffield Professor of Population Health and Head of the Nuffield Department of Population Health. He will succeed Professor Sir Rory Collins who has been Head of Department since its inception in 2013.

December 2024 - Volunteer opportunities

Nuffield Department of Women's & Reproductive Health (NDWRH) Celebrates Athena Swan Gold Award Success

The Nuffield Department of Women's & Reproductive Health at the University of Oxford (NDWRH) is proud to announce that on Monday 23 September 2024, the department was awarded the prestigious Athena Swan Gold Award. This achievement follows a rigorous and substantial application process, reaffirming the department’s commitment to gender equality and the promotion of diversity within science and higher education.

Professor Sir Aziz Sheikh OBE starts as new Head of the Nuffield Department of Primary Care Health Sciences

Professor Sir Aziz Sheikh takes over the role of Head of Department from Professor Richard Hobbs CBE from 1 October 2024

New GSK collaboration will develop use of biostatistics and AI in research

With a base in the University's Nuffield Department of Medicine and Department of Statistics, the collaboration will draw upon biostatistical and artificial intelligence (AI) expertise across Oxford, prioritising the development of innovative new tools and methods that translate to medical and biopharmaceutical research.

Load More